HighTower Advisors
AFIB

HighTower Advisors’s Acutus Medical Inc AFIB Stock Holding History

HighTower Advisors’s Portfolio AFIB Stock Details AFIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-80,000
Closed -$8K – 3460
2022
Q2 		$8K Buy
80,000
+79,200
+9,900% +$68K ﹤0.01% 3085
2022
Q1 		$20K Buy
+800
New +$1.71K ﹤0.01% 3168

Other funds holding AFIB

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AFG
American Financial Group Cincinnati, Ohio $270M AUM 3.25% 1-Year Est. Return
KSCM
Kamunting Street Capital Management Miami Beach, Florida $183M AUM 2.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

HighTower Advisors's AFIB Position: Q4 2022 in Review

HighTower Advisors sold out of Acutus Medical Inc (AFIB) in Q4 2022, closing a stake of 250,498 shares — an estimated $220K sold.

HighTower Advisors first reported a position in AFIB in Q3 2020 and held it in 9 quarters. The position peaked at $1.17M in Q2 2021. 38 funds tracked by Wall St. Rank hold AFIB as of Q4 2022.

  • HighTower Advisors reported no remaining Acutus Medical Inc position as of Q4 2022 after selling out during the quarter.
  • HighTower Advisors sold 250,498 Acutus Medical Inc shares in Q4 2022, an estimated $220K.
  • HighTower Advisors first reported a position in Acutus Medical Inc in Q3 2020 and held it in 9 quarters.
  • HighTower Advisors's Acutus Medical Inc position peaked at $1.17M in Q2 2021.
  • 38 funds tracked by Wall St. Rank held Acutus Medical Inc as of Q4 2022.

Based on HighTower Advisors's 13F filing for Q4 2022, filed 9 Feb 2023.